Clicky

Quoin Pharmaceuticals, Ltd.(QNRX)

Description: Founded in 2018 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others.


Keywords: Medicine Pharmaceutical Clinical Medicine Therapeutic Products Genodermatoses Epidermolysis Bullosa Rare And Orphan Diseases Netherton Syndrome

Home Page: quoinpharma.com

QNRX Technical Analysis

42127 Pleasant Forest Court
Ashburn, VA 20148-7349
United States
Phone: 703 980 4182


Officers

Name Title
Dr. Michael Myers Ph.D. Co-Founder, CEO & Chairman
Ms. Denise Carter Co-Founder, COO & Director
Mr. Gordon Bruce Dunn J.D. Chief Financial Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.8247
Price-to-Sales TTM: 0
IPO Date: 2016-07-29
Fiscal Year End: December
Full Time Employees: 4
Back to stocks